What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Christian Brambilla focuses on Cancer research, Lung cancer, Pathology, Cancer and Adenocarcinoma.
His Cancer research study combines topics in areas such as Gene expression profiling, Transcriptome, Tumor suppressor gene, Histone and Epigenetics.
His Lung cancer study is related to the wider topic of Internal medicine.
In his study, Predictive marker, Atypical adenomatous hyperplasia and KRAS is strongly linked to Oncology, which falls under the umbrella field of Internal medicine.
His Pathology research incorporates elements of Receptor and Angiogenesis.
His Adenocarcinoma research includes themes of Lung, Proto-oncogene tyrosine-protein kinase Src and Gefitinib.
His most cited work include:
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3017 citations)
- American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias (3012 citations)
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer (845 citations)
What are the main themes of his work throughout his whole career to date?
Christian Brambilla mostly deals with Lung cancer, Pathology, Cancer research, Internal medicine and Cancer.
His Lung cancer research focuses on subjects like Adenocarcinoma, which are linked to Gene expression.
His Pathology study integrates concerns from other disciplines, such as Respiratory disease, Lung and Large cell.
While the research belongs to areas of Cancer research, Christian Brambilla spends his time largely on the problem of Cell, intersecting his research to questions surrounding Molecular biology.
The Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Oncology.
Christian Brambilla works mostly in the field of Cancer, limiting it down to concerns involving DNA methylation and, occasionally, Regulation of gene expression.
He most often published in these fields:
- Lung cancer (36.09%)
- Pathology (32.17%)
- Cancer research (33.04%)
What were the highlights of his more recent work (between 2006-2020)?
- Cancer research (33.04%)
- Lung cancer (36.09%)
- Cancer (23.48%)
In recent papers he was focusing on the following fields of study:
Christian Brambilla focuses on Cancer research, Lung cancer, Cancer, Internal medicine and Oncology.
His work deals with themes such as Cell, E2F1, Downregulation and upregulation, Gene and Cyclin E, which intersect with Cancer research.
Lung cancer is a subfield of Pathology that he studies.
He has researched Cancer in several fields, including Respiratory disease, Regulation of gene expression and Somatic cell.
His Oncology study combines topics from a wide range of disciplines, such as Progressive disease, Genotyping, Primary tumor, Metastasis and Survival analysis.
His study in Adenocarcinoma is interdisciplinary in nature, drawing from both Angiogenesis, Gene expression, KRAS, Lung and Gefitinib.
Between 2006 and 2020, his most popular works were:
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3017 citations)
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer (845 citations)
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer (682 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Cancer research, Cancer, Lung cancer, Adenocarcinoma and Internal medicine.
His Cancer research study combines topics in areas such as Gene expression profiling, E2F1, Apoptosis and Epigenetics, Gene.
His Cancer research includes elements of Pathology, Ectopic expression, Bioinformatics and Somatic cell.
His studies in Lung cancer integrate themes in fields like Biomarker and Circulating free DNA.
The various areas that Christian Brambilla examines in his Adenocarcinoma study include Lung, Erlotinib and Gefitinib.
His studies link Oncology with Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
